De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors
Keywords: پیشرفت; Mutation; Small cell lung cancer; Large cell neuroendocrine carcinoma; EGFR; Never-smoker; Erlotinib; Progression; Resistance;